US Stock MarketDetailed Quotes

NKGN NKGEN BIOTECH

Watchlist

0.372
-0.045-10.72%

Close Nov 27 16:00 ET

0.379
+0.006+1.69%

Post 19:21 ET

13.22MMarket Cap-98P/E (TTM)

NKGEN BIOTECH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-8.48%-6M

17.91%-4.03M

2.70%-21.95M

-26.95%-6.94M

-4.57M

-5.53M

-4.91M

-15.39%-22.56M

-5.47M

-19.55M

Net income from continuing operations

-104.97%-16.09M

35.33%-5.38M

-210.06%-82.95M

-383.68%-33.61M

---33.18M

---7.85M

---8.32M

-15.00%-26.75M

---6.95M

---23.27M

Operating gains losses

--9.47M

---4.53M

--48.2M

--23.73M

----

Depreciation and amortization

9.03%326K

7.24%326K

-0.58%1.2M

-1.96%300K

--300K

--299K

--304K

-2.73%1.21M

--306K

--1.24M

Other non cash items

51.11%-662K

32.27%2.16M

54.74%4.2M

-59.14%293K

--3.63M

---1.35M

--1.63M

107.74%2.71M

--717K

--1.31M

Change In working capital

131.38%123K

953.24%2.28M

7,320.00%2.23M

299.15%1.42M

--985K

---392K

--216K

-96.78%30K

--355K

--932K

-Change in receivables

--0

200.00%29K

--0

--29K

-126.13%-29K

--16K

--111K

-Change in prepaid assets

352.83%402K

340.88%330K

-2,561.40%-1.4M

-451.92%-366K

---741K

---159K

---137K

218.75%57K

--104K

---48K

-Change in payables and accrued expense

-112.32%-293K

325.00%1.85M

801.35%3.99M

437.78%1.89M

--1.8M

---138K

--436K

-53.81%443K

--352K

--959K

-Change in other current liabilities

114.29%13K

193.94%93K

13.27%-379K

12.73%-96K

---93K

---91K

---99K

-276.72%-437K

---110K

---116K

-Change in other working capital

----

92.31%-1K

-250.00%-14K

----

---4K

---13K

-115.38%-4K

---7K

--26K

Cash from discontinued investing activities

Operating cash flow

-8.48%-6M

17.91%-4.03M

2.70%-21.95M

-26.95%-6.94M

---4.57M

---5.53M

---4.91M

-15.39%-22.56M

---5.47M

---19.55M

Investing cash flow

Cash flow from continuing investing activities

11.76%-15K

369.23%35K

70.55%-48K

-260.00%-18K

-17K

-13K

64.49%-163K

-5K

-459K

Capital expenditure reported

11.76%-15K

--0

22.58%-48K

-38.46%-18K

--0

---17K

---13K

-10.71%-62K

---13K

---56K

Net PPE purchase and sale

--0

--35K

--0

74.94%-101K

--8K

---403K

Cash from discontinued investing activities

Investing cash flow

11.76%-15K

369.23%35K

70.55%-48K

-260.00%-18K

--0

---17K

---13K

64.49%-163K

---5K

---459K

Financing cash flow

Cash flow from continuing financing activities

-3.38%6.06M

-27.91%4.01M

-1.47%22.16M

-132.78%-1.8M

12.13M

6.27M

5.56M

11.54%22.49M

5.5M

20.16M

Net issuance payments of debt

-19.85%6.49M

-73.46%1.47M

17.38%26.21M

-104.36%-240K

--12.79M

--8.1M

--5.55M

11.09%22.33M

--5.5M

--20.1M

Net common stock issuance

----

--1.67M

--1K

--1.67M

----

--0

----

Proceeds from stock option exercised by employees

--0

6,150.00%250K

6,249.07%10.22M

--0

--10.21M

--8K

--4K

155.56%161K

--1K

--63K

Net other financing activities

---1.31M

--2.28M

---15.94M

---1.56M

---12.54M

----

Cash from discontinued financing activities

Financing cash flow

-3.38%6.06M

-27.91%4.01M

-1.47%22.16M

-132.78%-1.8M

--12.13M

--6.27M

--5.56M

11.54%22.49M

--5.5M

--20.16M

Net cash flow

Beginning cash position

-62.03%284K

135.90%276K

-66.67%117K

10,286.21%9.04M

--1.47M

--748K

--117K

76.38%351K

--87K

--199K

Current changes in cash

-93.78%45K

-98.73%8K

167.95%159K

-29,300.00%-8.76M

--7.56M

--724K

--631K

-253.95%-234K

--30K

--152K

End cash Position

-77.65%329K

-62.03%284K

135.90%276K

--9.04M

--1.47M

--748K

-66.67%117K

--117K

--351K

Free cash flow

-8.42%-6.01M

18.12%-4.03M

3.19%-22M

-27.16%-6.96M

---4.57M

---5.55M

---4.93M

-13.56%-22.72M

---5.47M

---20.01M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-8.48%-6M	17.91%-4.03M	2.70%-21.95M	-26.95%-6.94M	-4.57M	-5.53M	-4.91M	-15.39%-22.56M	-5.47M	-19.55M
Net income from continuing operations	-104.97%-16.09M	35.33%-5.38M	-210.06%-82.95M	-383.68%-33.61M	---33.18M	---7.85M	---8.32M	-15.00%-26.75M	---6.95M	---23.27M
Operating gains losses	--9.47M	---4.53M	--48.2M	--23.73M	----	----	----	----	----	----
Depreciation and amortization	9.03%326K	7.24%326K	-0.58%1.2M	-1.96%300K	--300K	--299K	--304K	-2.73%1.21M	--306K	--1.24M
Other non cash items	51.11%-662K	32.27%2.16M	54.74%4.2M	-59.14%293K	--3.63M	---1.35M	--1.63M	107.74%2.71M	--717K	--1.31M
Change In working capital	131.38%123K	953.24%2.28M	7,320.00%2.23M	299.15%1.42M	--985K	---392K	--216K	-96.78%30K	--355K	--932K
-Change in receivables	--0	--0	200.00%29K	--0	--0	--0	--29K	-126.13%-29K	--16K	--111K
-Change in prepaid assets	352.83%402K	340.88%330K	-2,561.40%-1.4M	-451.92%-366K	---741K	---159K	---137K	218.75%57K	--104K	---48K
-Change in payables and accrued expense	-112.32%-293K	325.00%1.85M	801.35%3.99M	437.78%1.89M	--1.8M	---138K	--436K	-53.81%443K	--352K	--959K
-Change in other current liabilities	114.29%13K	193.94%93K	13.27%-379K	12.73%-96K	---93K	---91K	---99K	-276.72%-437K	---110K	---116K
-Change in other working capital	----	92.31%-1K	-250.00%-14K	----	----	---4K	---13K	-115.38%-4K	---7K	--26K
Cash from discontinued investing activities
Operating cash flow	-8.48%-6M	17.91%-4.03M	2.70%-21.95M	-26.95%-6.94M	---4.57M	---5.53M	---4.91M	-15.39%-22.56M	---5.47M	---19.55M
Investing cash flow
Cash flow from continuing investing activities	11.76%-15K	369.23%35K	70.55%-48K	-260.00%-18K	0	-17K	-13K	64.49%-163K	-5K	-459K
Capital expenditure reported	11.76%-15K	--0	22.58%-48K	-38.46%-18K	--0	---17K	---13K	-10.71%-62K	---13K	---56K
Net PPE purchase and sale	--0	--35K	--0	--0	--0	--0	--0	74.94%-101K	--8K	---403K
Cash from discontinued investing activities
Investing cash flow	11.76%-15K	369.23%35K	70.55%-48K	-260.00%-18K	--0	---17K	---13K	64.49%-163K	---5K	---459K
Financing cash flow
Cash flow from continuing financing activities	-3.38%6.06M	-27.91%4.01M	-1.47%22.16M	-132.78%-1.8M	12.13M	6.27M	5.56M	11.54%22.49M	5.5M	20.16M
Net issuance payments of debt	-19.85%6.49M	-73.46%1.47M	17.38%26.21M	-104.36%-240K	--12.79M	--8.1M	--5.55M	11.09%22.33M	--5.5M	--20.1M
Net common stock issuance	----	----	--1.67M	--1K	--1.67M	----	----	--0	--0	----
Proceeds from stock option exercised by employees	--0	6,150.00%250K	6,249.07%10.22M	--0	--10.21M	--8K	--4K	155.56%161K	--1K	--63K
Net other financing activities	---1.31M	--2.28M	---15.94M	---1.56M	---12.54M	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-3.38%6.06M	-27.91%4.01M	-1.47%22.16M	-132.78%-1.8M	--12.13M	--6.27M	--5.56M	11.54%22.49M	--5.5M	--20.16M
Net cash flow
Beginning cash position	-62.03%284K	135.90%276K	-66.67%117K	10,286.21%9.04M	--1.47M	--748K	--117K	76.38%351K	--87K	--199K
Current changes in cash	-93.78%45K	-98.73%8K	167.95%159K	-29,300.00%-8.76M	--7.56M	--724K	--631K	-253.95%-234K	--30K	--152K
End cash Position	-77.65%329K	-62.03%284K	135.90%276K	135.90%276K	--9.04M	--1.47M	--748K	-66.67%117K	--117K	--351K
Free cash flow	-8.42%-6.01M	18.12%-4.03M	3.19%-22M	-27.16%-6.96M	---4.57M	---5.55M	---4.93M	-13.56%-22.72M	---5.47M	---20.01M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data